| term overlap_mean setsize_mean score_mean pval_mean overlap_std setsize_std score_std pval_std |
| 2 ltr circle formation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| A tetrasaccharide linker sequence is required for gag synthesis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abacavir metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abacavir transmembrane transport 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abacavir transport and metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abc family proteins mediated transport 1.0 75.0 1.368004368004368 0.523802502209471 0.0 0.0 0.0 0.0 |
| Abc transporter disorders 1.0 61.0 1.6895622895622897 0.4528388306838392 0.0 0.0 0.0 0.0 |
| Abc transporters in lipid homeostasis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aberrant regulation of mitotic exit in cancer due to rb1 defects 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aberrant regulation of mitotic g1 s transition in cancer due to rb1 defects 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Abortive elongation of hiv 1 transcript in the absence of tat 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acetylcholine binding and downstream events 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acetylcholine neurotransmitter release cycle 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acetylcholine regulates insulin secretion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acrosome reaction and sperm oocyte membrane binding 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated notch1 transmits signal to the nucleus 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through cdk5 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through frs2 and frs3 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through fyn 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through pi3k 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk2 signals through ras 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk3 signals through pi3k 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated ntrk3 signals through ras 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated pkn1 stimulates transcription of ar androgen receptor regulated genes klk2 and klk3 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activated tak1 mediates p38 mapk activation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ampk downstream of nmdars 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of anterior hox genes in hindbrain development during early embryogenesis 0.0 60.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of atr in response to replication stress 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of bad and translocation to mitochondria 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of bh3 only proteins 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of c3 and c5 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of caspases through apoptosome mediated cleavage 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of gene expression by srebf srebp 1.0 42.0 2.477211135747721 0.339526513295544 0.0 0.0 0.0 0.0 |
| Activation of irf3 irf7 mediated by tbk1 ikk epsilon 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of kainate receptors upon glutamate binding 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of matrix metalloproteinases 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of nima kinases nek9 nek6 nek7 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of nmda receptors and postsynaptic events 0.0 68.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of noxa and translocation to mitochondria 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ppargc1a pgc 1alpha by phosphorylation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of puma and translocation to mitochondria 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of rac1 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of rac1 downstream of nmdars 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of ras in b cells 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of smo 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the ap 1 family of transcription factors 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the mrna upon binding of the cap binding complex and eifs and subsequent binding to 43s 0.0 59.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the phototransduction cascade 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the pre replicative complex 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of the tfap2 ap 2 family of transcription factors 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Activation of trka receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodeling of cl 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodeling of dag and tag 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pc 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pe 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pg 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of pi 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Acyl chain remodelling of ps 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adaptive immune system 4.0 504.0 0.7996666666666666 0.7353203956734597 0.0 0.0 0.0 0.0 |
| Adenylate cyclase activating pathway 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adenylate cyclase inhibitory pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adherens junctions interactions 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adora2b mediated anti inflammatory cytokines production 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adp signalling through p2y purinoceptor 1 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adp signalling through p2y purinoceptor 12 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Adrenaline noradrenaline inhibits insulin secretion 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Advanced glycosylation endproduct receptor signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aflatoxin activation and detoxification 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aggrephagy 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Akt phosphorylates targets in the cytosol 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Akt phosphorylates targets in the nucleus 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alk mutants bind tkis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha defensins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha linolenic omega3 and linoleic omega6 acid metabolism 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alpha oxidation of phytanate 1.0 6.0 10.0 0.0574361921538736 0.0 0.0 0.0 0.0 |
| Alpha protein kinase 1 signaling pathway 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Alternative complement activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Amino acid transport across the plasma membrane 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Amino acids regulate mtorc1 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ampk inhibits chrebp transcriptional activation activity 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Amyloid fiber formation 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anchoring fibril formation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anchoring of the basal body to the plasma membrane 0.0 95.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Androgen biosynthesis 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Anti inflammatory response favouring leishmania parasite infection 0.0 46.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antigen activates b cell receptor bcr leading to generation of second messengers 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antigen presentation folding assembly and peptide loading of class i mhc 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antigen processing cross presentation 2.0 77.0 2.726802721088436 0.1744223041589415 0.0 0.0 0.0 0.0 |
| Antigen processing ubiquitination proteasome degradation 3.0 250.0 1.233231770942026 0.4458029496368113 0.0 0.0 0.0 0.0 |
| Antimicrobial peptides 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Antiviral mechanism by ifn stimulated genes 1.0 73.0 1.4062850729517395 0.5142525268330266 0.0 0.0 0.0 0.0 |
| Apc c cdc20 mediated degradation of cyclin b 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apc c cdh1 mediated degradation of cdc20 and other apc c cdh1 targeted proteins in late mitosis early g1 1.0 68.0 1.5119855269109 0.4895400608205746 0.0 0.0 0.0 0.0 |
| Apc c mediated degradation of cell cycle proteins 1.0 81.0 1.2646464646464646 0.5513512032975088 0.0 0.0 0.0 0.0 |
| Apc cdc20 mediated degradation of nek2a 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apex1 independent resolution of ap sites via the single nucleotide replacement pathway 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apobec3g mediated resistance to hiv 1 infection 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptosis 1.0 159.0 0.6353407492647999 0.7939144122287346 0.0 0.0 0.0 0.0 |
| Apoptosis induced dna fragmentation 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptotic cleavage of cell adhesion proteins 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptotic cleavage of cellular proteins 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptotic execution phase 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Apoptotic factor mediated response 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aquaporin mediated transport 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Arachidonate production from dag 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Arachidonic acid metabolism 1.0 18.0 5.98871063576946 0.1626892876910785 0.0 0.0 0.0 0.0 |
| Arms mediated activation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Aryl hydrocarbon receptor signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Asparagine n linked glycosylation 2.0 245.0 0.8274964306710338 0.6973839006897755 0.0 0.0 0.0 0.0 |
| Aspartate and asparagine metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly and cell surface presentation of nmda receptors 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of active lpl and lipc lipase complexes 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of collagen fibrils and other multimeric structures 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of the hiv virion 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Assembly of the orc complex at the origin of replication 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Association of tric cct with target proteins during biosynthesis 1.0 36.0 2.903607503607504 0.299132167535026 0.0 0.0 0.0 0.0 |
| Asymmetric localization of pcp proteins 1.0 54.0 1.914046121593292 0.4135270958140081 0.0 0.0 0.0 0.0 |
| Atf4 activates genes in response to endoplasmic reticulum stress 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Atf6 atf6 alpha activates chaperone genes 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Atf6 atf6 alpha activates chaperones 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Attachment and entry 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Attachment of gpi anchor to upar 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Attenuation phase 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Auf1 hnrnp d0 binds and destabilizes mrna 1.0 48.0 2.1596819256393727 0.3776146865857887 0.0 0.0 0.0 0.0 |
| Aurka activation by tpx2 0.0 73.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Autophagy 3.0 130.0 2.4277132884162675 0.1352776549759777 0.0 0.0 0.0 0.0 |
| B wich complex positively regulates rrna expression 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Base excision repair 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Base excision repair ap site formation 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Basigin interactions 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bbsome mediated cargo targeting to cilium 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta catenin independent wnt signaling 1.0 117.0 0.869035179380007 0.6864562302095232 0.0 0.0 0.0 0.0 |
| Beta catenin phosphorylation cascade 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of butanoyl coa to acetyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of decanoyl coa to octanoyl coa coa 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of hexanoyl coa to butanoyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of lauroyl coa to decanoyl coa coa 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of octanoyl coa to hexanoyl coa 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of pristanoyl coa 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Beta oxidation of very long chain fatty acids 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bh3 only proteins associate with and inactivate anti apoptotic bcl 2 members 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bicarbonate transporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bile acid and bile salt metabolism 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Binding and uptake of ligands by scavenger receptors 1.0 17.0 6.363636363636363 0.1543818096433915 0.0 0.0 0.0 0.0 |
| Binding of tcf lef ctnnb1 to target gene promoters 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biological oxidations 4.0 94.0 4.632407407407407 0.0135552020851603 0.0 0.0 0.0 0.0 |
| Biosynthesis of epa derived spms 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of maresins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of specialized proresolving mediators spms 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Biosynthesis of the n glycan precursor dolichol lipid linked oligosaccharide llo and transfer to a nascent protein 1.0 59.0 1.748171368861024 0.4418810858922499 0.0 0.0 0.0 0.0 |
| Biotin transport and metabolism 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Blood group systems biosynthesis 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Bmal1 clock npas2 activates circadian gene expression 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Branched chain amino acid catabolism 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Budding and maturation of hiv virion 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Butyrate response factor 1 brf1 binds and destabilizes mrna 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Butyrophilin btn family interactions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| C type lectin receptors clrs 1.0 100.0 1.0199979593918989 0.6285936102034135 0.0 0.0 0.0 0.0 |
| Ca dependent events 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ca2 pathway 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Calcineurin activates nfat 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Calnexin calreticulin cycle 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Camk iv mediated phosphorylation of creb 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Carboxyterminal post translational modifications of tubulin 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cardiac conduction 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cargo concentration in the er 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cargo recognition for clathrin mediated endocytosis 1.0 78.0 1.3143119506755871 0.5377799970023095 0.0 0.0 0.0 0.0 |
| Cargo trafficking to the periciliary membrane 1.0 43.0 2.417989417989418 0.3460310778663031 0.0 0.0 0.0 0.0 |
| Carnitine metabolism 2.0 12.0 10.0 0.0058956460302812 0.0 0.0 0.0 0.0 |
| Caspase activation via death receptors in the presence of ligand 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase activation via dependence receptors in the absence of ligand 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase activation via extrinsic apoptotic signalling pathway 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Caspase mediated cleavage of cytoskeletal proteins 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cation coupled chloride cotransporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd163 mediating an anti inflammatory response 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd209 dc sign signaling 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd22 mediated bcr regulation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 co stimulation 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 dependent pi3k akt signaling 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cd28 dependent vav1 pathway 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cdc42 gtpase cycle 1.0 134.0 0.7566643882433356 0.7353802816028594 0.0 0.0 0.0 0.0 |
| Cdc6 association with the orc origin complex 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cdt1 association with the cdc6 orc origin complex 1.0 54.0 1.914046121593292 0.4135270958140081 0.0 0.0 0.0 0.0 |
| Cell cell communication 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell cell junction organization 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell cycle 3.0 613.0 0.4809531857360148 0.9447406028696574 0.0 0.0 0.0 0.0 |
| Cell cycle checkpoints 1.0 257.0 0.3882575757575757 0.9231226762763804 0.0 0.0 0.0 0.0 |
| Cell cycle mitotic 3.0 498.0 0.5998750390502968 0.8729437805619555 0.0 0.0 0.0 0.0 |
| Cell death signalling via nrage nrif and nade 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell extracellular matrix interactions 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell junction organization 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cell surface interactions at the vascular wall 0.0 70.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular hexose transport 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular response to chemical stress 3.0 133.0 2.370975416336241 0.1420367484612055 0.0 0.0 0.0 0.0 |
| Cellular response to heat stress 1.0 93.0 1.098375054896794 0.6018020784024207 0.0 0.0 0.0 0.0 |
| Cellular response to hypoxia 1.0 59.0 1.748171368861024 0.4418810858922499 0.0 0.0 0.0 0.0 |
| Cellular response to starvation 0.0 139.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cellular responses to stimuli 6.0 614.0 0.996080627099664 0.5637228369249783 0.0 0.0 0.0 0.0 |
| Cellular senescence 0.0 131.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cgmp effects 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chaperone mediated autophagy 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chemokine receptors bind chemokines 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chk1 chk2 cds1 mediated inactivation of cyclin b cdk1 complex 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chl1 interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cholesterol biosynthesis 3.0 24.0 10.0 0.0015953295223005 0.0 0.0 0.0 0.0 |
| Choline catabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chondroitin sulfate biosynthesis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chondroitin sulfate dermatan sulfate metabolism 1.0 32.0 3.2795698924731185 0.27085351108605 0.0 0.0 0.0 0.0 |
| Chrebp activates metabolic gene expression 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chromatin modifying enzymes 0.0 210.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chromosome maintenance 0.0 100.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chylomicron assembly 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chylomicron clearance 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Chylomicron remodeling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cilium assembly 1.0 183.0 0.5502275502275502 0.837983208313382 0.0 0.0 0.0 0.0 |
| Circadian clock 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Citric acid cycle tca cycle 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Class a 1 rhodopsin like receptors 2.0 21.0 10.0 0.0177148463510605 0.0 0.0 0.0 0.0 |
| Class b 2 secretin family receptors 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Class i mhc mediated antigen processing presentation 3.0 295.0 1.038412653580003 0.5565287971930715 0.0 0.0 0.0 0.0 |
| Class i peroxisomal membrane protein import 2.0 19.0 10.0 0.0146091852998709 0.0 0.0 0.0 0.0 |
| Clathrin mediated endocytosis 1.0 119.0 0.8541345659989728 0.6926473948093821 0.0 0.0 0.0 0.0 |
| Clec7a dectin 1 induces nfat activation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Clec7a dectin 1 signaling 1.0 85.0 1.203944203944204 0.5688343041108967 0.0 0.0 0.0 0.0 |
| Clec7a inflammasome pathway 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cobalamin cbl vitamin b12 transport and metabolism 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Coenzyme a biosynthesis 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cohesin loading onto chromatin 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen biosynthesis and modifying enzymes 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen chain trimerization 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen degradation 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Collagen formation 0.0 44.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Common pathway of fibrin clot formation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Competing endogenous rnas cernas regulate pten translation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Complement cascade 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Complex i biogenesis 2.0 56.0 3.795162509448224 0.1043706933170995 0.0 0.0 0.0 0.0 |
| Condensation of prometaphase chromosomes 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Condensation of prophase chromosomes 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by aberrant pi3k in cancer 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by akt1 e17k in cancer 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by egfrviii 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by ligand responsive egfr cancer variants 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Constitutive signaling by overexpressed erbb2 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Conversion from apc c cdc20 to apc c cdh1 in late anaphase 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cooperation of pdcl phlp1 and tric cct in g protein beta folding 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cooperation of prefoldin and tric cct in actin and tubulin folding 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Copi dependent golgi to er retrograde traffic 2.0 83.0 2.5233056185437137 0.195637464602177 0.0 0.0 0.0 0.0 |
| Copi independent golgi to er retrograde traffic 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Copi mediated anterograde transport 1.0 89.0 1.1487603305785123 0.5856426665825264 0.0 0.0 0.0 0.0 |
| Copii mediated vesicle transport 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Costimulation by the cd28 family 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creatine metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb phosphorylation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through nmda receptor mediated activation of ras signaling 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through the activation of adenylate cyclase 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb1 phosphorylation through the activation of camkii camkk camkiv cascasde 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Creb3 factors activate genes 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cristae formation 2.0 27.0 8.221224489795919 0.0285062952815799 0.0 0.0 0.0 0.0 |
| Crmps in sema3a signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cross presentation of particulate exogenous antigens phagosomes 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cross presentation of soluble exogenous antigens endosomes 1.0 41.0 2.5393939393939395 0.3329579057594876 0.0 0.0 0.0 0.0 |
| Crosslinking of collagen fibrils 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cs ds degradation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ctla4 inhibitory signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cyclin a b1 b2 associated events during g2 m transition 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cyclin a cdk2 associated events at s phase entry 1.0 79.0 1.2973322973322974 0.5423482911753763 0.0 0.0 0.0 0.0 |
| Cyclin d associated events in g1 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cyp2e1 reactions 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytochrome c mediated apoptotic response 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytochrome p450 arranged by substrate type 1.0 15.0 7.274170274170274 0.1375212864755611 0.0 0.0 0.0 0.0 |
| Cytokine signaling in immune system 4.0 392.0 1.0425257731958764 0.5397867020054197 0.0 0.0 0.0 0.0 |
| Cytoprotection by hmox1 3.0 110.0 2.8872723769149244 0.0934596512163871 0.0 0.0 0.0 0.0 |
| Cytosolic iron sulfur cluster assembly 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytosolic sensors of pathogen associated dna 0.0 56.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Cytosolic sulfonation of small molecules 1.0 14.0 7.834498834498834 0.1289666473793992 0.0 0.0 0.0 0.0 |
| Cytosolic trna aminoacylation 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dag and ip3 signaling 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dap12 interactions 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dap12 signaling 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Darpp 32 events 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dcc mediated attractive signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ddx58 ifih1 mediated induction of interferon alpha beta 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deactivation of the beta catenin transactivating complex 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deadenylation dependent mrna decay 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deadenylation of mrna 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Death receptor signalling 1.0 120.0 0.8468720821661998 0.6956974355499302 0.0 0.0 0.0 0.0 |
| Dectin 1 mediated noncanonical nf kb signaling 1.0 53.0 1.951048951048951 0.4076874771235006 0.0 0.0 0.0 0.0 |
| Dectin 2 family 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective b4galt1 causes b4galt1 cdg cdg 2d 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective b4galt7 causes eds progeroid type 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective c1galt1c1 causes tnps 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective cftr causes cystic fibrosis 1.0 54.0 1.914046121593292 0.4135270958140081 0.0 0.0 0.0 0.0 |
| Defective chst14 causes eds musculocontractural type 1.0 4.0 10.0 0.0386632862857637 0.0 0.0 0.0 0.0 |
| Defective chst3 causes sedcjd 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chst6 causes mcdc1 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective chsy1 causes tpbs 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective ext2 causes exostoses 2 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective f9 activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective factor ix causes hemophilia b 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective factor viii causes hemophilia a 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective galnt3 causes hftc 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective intrinsic pathway for apoptosis 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective lfng causes scdo3 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defective ripk1 mediated regulated necrosis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in biotin btn metabolism 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in cobalamin b12 metabolism 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects in vitamin and cofactor metabolism 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defects of contact activation system cas and kallikrein kinin system kks 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Defensins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Degradation of axin 1.0 48.0 2.1596819256393727 0.3776146865857887 0.0 0.0 0.0 0.0 |
| Degradation of beta catenin by the destruction complex 1.0 77.0 1.331738437001595 0.5331665625078387 0.0 0.0 0.0 0.0 |
| Degradation of cysteine and homocysteine 1.0 12.0 9.26078971533517 0.1116045715736199 0.0 0.0 0.0 0.0 |
| Degradation of dvl 1.0 50.0 2.0711193568336426 0.3898210156705143 0.0 0.0 0.0 0.0 |
| Degradation of gli1 by the proteasome 1.0 53.0 1.951048951048951 0.4076874771235006 0.0 0.0 0.0 0.0 |
| Degradation of the extracellular matrix 0.0 56.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Depolymerisation of the nuclear lamina 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deposition of new cenpa containing nucleosomes at the centromere 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dermatan sulfate biosynthesis 1.0 6.0 10.0 0.0574361921538736 0.0 0.0 0.0 0.0 |
| Detoxification of reactive oxygen species 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Deubiquitination 3.0 221.0 1.4013997919228225 0.3692440438139568 0.0 0.0 0.0 0.0 |
| Developmental biology 3.0 665.0 0.440745008876569 0.9628896099713954 0.0 0.0 0.0 0.0 |
| Dex h box helicases activate type i ifn and inflammatory cytokines production 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Digestion 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Digestion and absorption 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Disassembly of the destruction complex and recruitment of axin to the membrane 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases associated with glycosaminoglycan metabolism 1.0 26.0 4.069090909090909 0.2263045436956677 0.0 0.0 0.0 0.0 |
| Diseases associated with glycosylation precursor biosynthesis 1.0 16.0 6.788552188552188 0.1459927402947744 0.0 0.0 0.0 0.0 |
| Diseases associated with n glycosylation of proteins 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases associated with o glycosylation of proteins 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases associated with surfactant metabolism 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of base excision repair 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of carbohydrate metabolism 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of dna repair 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of glycosylation 2.0 76.0 2.7639271924986213 0.1709242062681763 0.0 0.0 0.0 0.0 |
| Diseases of immune system 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of metabolism 2.0 131.0 1.5768074671729158 0.3689201181216821 0.0 0.0 0.0 0.0 |
| Diseases of mismatch repair mmr 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of mitotic cell cycle 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of programmed cell death 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Diseases of signal transduction by growth factor receptors and second messengers 2.0 333.0 0.6020716443677169 0.8432378625648937 0.0 0.0 0.0 0.0 |
| Disinhibition of snare formation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Disorders of transmembrane transporters 2.0 115.0 1.8029618927216904 0.3116411944565507 0.0 0.0 0.0 0.0 |
| Displacement of dna glycosylase by apex1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dissolution of fibrin clot 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage bypass 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage recognition in gg ner 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage reversal 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna damage telomere stress induced senescence 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna double strand break repair 0.0 137.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna double strand break response 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna methylation 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna repair 0.0 291.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna replication 1.0 137.0 0.7397504456327986 0.743192575047898 0.0 0.0 0.0 0.0 |
| Dna replication initiation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dna replication pre initiation 1.0 92.0 1.1105561105561106 0.5978216913417371 0.0 0.0 0.0 0.0 |
| Dna strand elongation 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dopamine clearance from the synaptic cleft 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dopamine neurotransmitter release cycle 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of erbb2 erbb3 signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of erbb2 signaling 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of erbb4 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of smad2 3 smad4 transcriptional activity 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downregulation of tgf beta receptor signaling 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signal transduction 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling events of b cell receptor bcr 1.0 71.0 1.446753246753247 0.5045129832066302 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr1 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr2 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr3 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Downstream signaling of activated fgfr4 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dscam interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dual incision in gg ner 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Dual incision in tc ner 0.0 67.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| E2f enabled inhibition of pre replication complex formation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| E2f mediated regulation of dna replication 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| E3 ubiquitin ligases ubiquitinate target proteins 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Early phase of hiv life cycle 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ecm proteoglycans 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Effects of pip2 hydrolysis 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr downregulation 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr interacts with phospholipase c gamma 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egfr transactivation by gastrin 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Egr2 and sox10 mediated initiation of schwann cell myelination 2.0 20.0 10.0 0.0161297090986061 0.0 0.0 0.0 0.0 |
| Eicosanoids 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Elastic fibre formation 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Electric transmission across gap junctions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Elevation of cytosolic ca2 levels 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Endogenous sterols 1.0 12.0 9.26078971533517 0.1116045715736199 0.0 0.0 0.0 0.0 |
| Endosomal sorting complex required for transport escrt 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Endosomal vacuolar pathway 1.0 10.0 10.0 0.0938999510605359 0.0 0.0 0.0 0.0 |
| Energy dependent regulation of mtor by lkb1 ampk 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Enos activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eph ephrin mediated repulsion of cells 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eph ephrin signaling 0.0 80.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Epha mediated growth cone collapse 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ephb mediated forward signaling 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ephrin signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Epigenetic regulation of gene expression 0.0 102.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Er quality control compartment erqc 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Er to golgi anterograde transport 1.0 129.0 0.7866161616161617 0.7218336548647704 0.0 0.0 0.0 0.0 |
| Erbb2 activates ptk6 signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erbb2 regulates cell motility 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ercc6 csb and ehmt2 g9a positively regulate rrna expression 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erk mapk targets 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erks are inactivated 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythrocytes take up carbon dioxide and release oxygen 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythrocytes take up oxygen and release carbon dioxide 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates phosphoinositide 3 kinase pi3k 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates phospholipase c gamma plcg 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates ras 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Erythropoietin activates stat5 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Esr mediated signaling 0.0 136.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Establishment of sister chromatid cohesion 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen biosynthesis 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen dependent gene expression 0.0 90.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen dependent nuclear events downstream of esr membrane signaling 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Estrogen stimulated signaling through prkcz 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ethanol oxidation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eukaryotic translation elongation 0.0 89.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Eukaryotic translation initiation 0.0 116.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Export of viral ribonucleoproteins from nucleus 1.0 32.0 3.2795698924731185 0.27085351108605 0.0 0.0 0.0 0.0 |
| Extension of telomeres 0.0 52.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Extra nuclear estrogen signaling 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Extracellular matrix organization 0.0 131.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Extrinsic pathway of fibrin clot formation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Factors involved in megakaryocyte development and platelet production 0.0 117.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fanconi anemia pathway 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fasl cd95l signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fatty acid metabolism 5.0 117.0 4.69172932330827 0.0057849238806711 0.0 0.0 0.0 0.0 |
| Fatty acids bound to gpr40 ffar1 regulate insulin secretion 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fatty acyl coa biosynthesis 1.0 29.0 3.632034632034632 0.2489059409173845 0.0 0.0 0.0 0.0 |
| Fbxw7 mutants and notch1 in cancer 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fc epsilon receptor fceri signaling 1.0 108.0 0.9429812140092514 0.6570328218304677 0.0 0.0 0.0 0.0 |
| Fceri mediated ca 2 mobilization 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fceri mediated mapk activation 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fceri mediated nf kb activation 1.0 68.0 1.5119855269109 0.4895400608205746 0.0 0.0 0.0 0.0 |
| Fcgamma receptor fcgr dependent phagocytosis 2.0 72.0 2.9230320699708456 0.1570603590829851 0.0 0.0 0.0 0.0 |
| Fcgr activation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fcgr3a mediated il10 synthesis 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fertilization 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1 ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1 mutant receptor activation 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1b ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr1c ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2 alternative splicing 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2 ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2 mutant receptor activation 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2b ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr2c ligand binding and activation 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr3 ligand binding and activation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfr3b ligand binding and activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fgfrl1 modulation of fgfr1 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fibronectin matrix formation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling by cbl mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling in disease 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Flt3 signaling through src family kinases 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Folding of actin by cct tric 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of apoptosome 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of atp by chemiosmotic coupling 1.0 14.0 7.834498834498834 0.1289666473793992 0.0 0.0 0.0 0.0 |
| Formation of fibrin clot clotting cascade 1.0 9.0 10.0 0.0849171013653387 0.0 0.0 0.0 0.0 |
| Formation of incision complex in gg ner 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of rna pol ii elongation complex 0.0 58.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of senescence associated heterochromatin foci sahf 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of tc ner pre incision complex 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of the beta catenin tcf transactivating complex 0.0 38.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of the cornified envelope 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of the early elongation complex 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of tubulin folding intermediates by cct tric 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formation of xylulose 5 phosphate 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Formyl peptide receptors bind formyl peptides and many other ligands 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of cell cycle genes 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of cell death genes 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Foxo mediated transcription of oxidative stress metabolic and neuronal genes 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Free fatty acids regulate insulin secretion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr1 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr2 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr3 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Frs mediated fgfr4 signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fructose catabolism 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Fructose metabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha 12 13 signalling events 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha i signalling events 1.0 88.0 1.1620805758736794 0.5815024054643041 0.0 0.0 0.0 0.0 |
| G alpha q signalling events 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha s signalling events 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G alpha z signalling events 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G beta gamma signalling through cdc42 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G beta gamma signalling through pi3kgamma 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein activation 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein beta gamma signalling 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G protein mediated events 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G0 and early g1 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G1 s dna damage checkpoints 1.0 61.0 1.6895622895622897 0.4528388306838392 0.0 0.0 0.0 0.0 |
| G1 s specific transcription 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G2 m checkpoints 1.0 134.0 0.7566643882433356 0.7353802816028594 0.0 0.0 0.0 0.0 |
| G2 m dna damage checkpoint 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G2 m dna replication checkpoint 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| G2 phase 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gab1 signalosome 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba b receptor activation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba receptor activation 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gaba synthesis release reuptake and degradation 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Galactose catabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gamma carboxylation hypusine formation and arylsulfatase activation 1.0 29.0 3.632034632034632 0.2489059409173845 0.0 0.0 0.0 0.0 |
| Gamma carboxylation transport and amino terminal cleavage of proteins 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap filling dna repair synthesis and ligation in gg ner 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap junction assembly 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap junction degradation 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gap junction trafficking and regulation 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gastrin creb signalling pathway via pkc and mapk 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gdp fucose biosynthesis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gene and protein expression by jak stat signaling after interleukin 12 stimulation 1.0 33.0 3.176767676767677 0.2780273254227372 0.0 0.0 0.0 0.0 |
| Gene silencing by rna 1.0 75.0 1.368004368004368 0.523802502209471 0.0 0.0 0.0 0.0 |
| Generation of second messenger molecules 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gli proteins bind promoters of hh responsive genes to promote transcription 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Global genome nucleotide excision repair gg ner 0.0 87.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucagon like peptide 1 glp1 regulates insulin secretion 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucagon signaling in metabolic regulation 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glucagon type ligand receptors 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gluconeogenesis 1.0 25.0 4.239057239057239 0.2186221342412543 0.0 0.0 0.0 0.0 |
| Glucose metabolism 3.0 80.0 4.024233498460303 0.0437228444640497 0.0 0.0 0.0 0.0 |
| Glucuronidation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutamate and glutamine metabolism 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutamate neurotransmitter release cycle 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutathione conjugation 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glutathione synthesis and recycling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycerophospholipid biosynthesis 3.0 86.0 3.7310893056763135 0.0522493976540893 0.0 0.0 0.0 0.0 |
| Glycerophospholipid catabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen breakdown glycogenolysis 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen metabolism 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen storage diseases 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycogen synthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Glycolysis 2.0 66.0 3.1989795918367347 0.1367168788611213 0.0 0.0 0.0 0.0 |
| Glycosaminoglycan metabolism 2.0 70.0 3.009603841536615 0.1502138999638582 0.0 0.0 0.0 0.0 |
| Glycosphingolipid metabolism 4.0 33.0 10.0 0.0002865257018003 0.0 0.0 0.0 0.0 |
| Glyoxylate metabolism and glycine degradation 1.0 22.0 4.846079846079846 0.1951188871774342 0.0 0.0 0.0 0.0 |
| Golgi associated vesicle biogenesis 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Golgi cisternae pericentriolar stack reorganization 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Golgi to er retrograde transport 2.0 115.0 1.8029618927216904 0.3116411944565507 0.0 0.0 0.0 0.0 |
| Gp1b ix v activation signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Gpcr ligand binding 2.0 46.0 4.662337662337662 0.0746250944081647 0.0 0.0 0.0 0.0 |
| Gpvi mediated activation cascade 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb2 events in erbb2 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb2 sos provides linkage to mapk signaling for integrins 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Grb7 events in erbb2 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Growth hormone receptor signaling 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hats acetylate histones 0.0 90.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hcmv early events 1.0 79.0 1.2973322973322974 0.5423482911753763 0.0 0.0 0.0 0.0 |
| Hcmv infection 1.0 102.0 0.9995999599959996 0.6359150291554319 0.0 0.0 0.0 0.0 |
| Hcmv late events 1.0 62.0 1.661698956780924 0.4582375595260778 0.0 0.0 0.0 0.0 |
| Hdacs deacetylate histones 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdl assembly 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdl clearance 1.0 2.0 10.0 0.0195202957776364 0.0 0.0 0.0 0.0 |
| Hdl remodeling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdms demethylate histones 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdr through homologous recombination hrr 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdr through mmej alt nhej 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hdr through single strand annealing ssa 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hedgehog ligand biogenesis 1.0 53.0 1.951048951048951 0.4076874771235006 0.0 0.0 0.0 0.0 |
| Hedgehog off state 1.0 96.0 1.063370547581074 0.6135107249346667 0.0 0.0 0.0 0.0 |
| Hedgehog on state 1.0 70.0 1.4678670765627286 0.4995709622922107 0.0 0.0 0.0 0.0 |
| Heme biosynthesis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Heme degradation 2.0 7.0 10.0 0.0019368511639724 0.0 0.0 0.0 0.0 |
| Heme signaling 1.0 36.0 2.903607503607504 0.299132167535026 0.0 0.0 0.0 0.0 |
| Hemostasis 2.0 361.0 0.5535216872264226 0.8742554717506751 0.0 0.0 0.0 0.0 |
| Heparan sulfate heparin hs gag metabolism 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Highly calcium permeable nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Histidine catabolism 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hiv elongation arrest and recovery 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hiv infection 2.0 213.0 0.9560885965760711 0.6219100721739275 0.0 0.0 0.0 0.0 |
| Hiv life cycle 1.0 144.0 0.7030444303171576 0.7605444332681799 0.0 0.0 0.0 0.0 |
| Hiv transcription elongation 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hiv transcription initiation 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Homologous dna pairing and strand exchange 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Homology directed repair 0.0 106.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Host interactions of hiv factors 2.0 116.0 1.786967418546366 0.315260036101858 0.0 0.0 0.0 0.0 |
| Hs gag biosynthesis 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hs gag degradation 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hsf1 activation 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hsf1 dependent transactivation 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hsp90 chaperone cycle for steroid hormone receptors shr in the presence of ligand 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hur elavl1 binds and stabilizes mrna 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hyaluronan biosynthesis and export 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hyaluronan metabolism 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hyaluronan uptake and degradation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Hydrolysis of lpc 1.0 3.0 10.0 0.0291384996647827 0.0 0.0 0.0 0.0 |
| Ikba variant leads to eda id 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ikk complex recruitment mediated by rip1 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Il 6 type cytokine receptor ligand interactions 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Immunoregulatory interactions between a lymphoid and a non lymphoid cell 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inactivation of cdc42 and rac1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inactivation of csf3 g csf signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Incretin synthesis secretion and inactivation 1.0 14.0 7.834498834498834 0.1289666473793992 0.0 0.0 0.0 0.0 |
| Infection with mycobacterium tuberculosis 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Infectious disease 5.0 619.0 0.8127893022458427 0.7341260327641723 0.0 0.0 0.0 0.0 |
| Inflammasomes 1.0 12.0 9.26078971533517 0.1116045715736199 0.0 0.0 0.0 0.0 |
| Influenza infection 1.0 150.0 0.6743271642600501 0.77449002960189 0.0 0.0 0.0 0.0 |
| Inhibition of dna recombination at telomere 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inhibition of replication initiation of damaged dna by rb1 e2f1 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inhibition of the proteolytic activity of apc c required for the onset of anaphase by mitotic spindle checkpoint components 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Initial triggering of complement 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Initiation of nuclear envelope ne reformation 1.0 20.0 5.35725677830941 0.179062604831997 0.0 0.0 0.0 0.0 |
| Inla mediated entry of listeria monocytogenes into host cells 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Inlb mediated entry of listeria monocytogenes into host cell 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Innate immune system 10.0 624.0 1.7158885269634456 0.0847619396978676 0.0 0.0 0.0 0.0 |
| Inositol phosphate metabolism 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insertion of tail anchored proteins into the endoplasmic reticulum membrane 3.0 19.0 10.0 0.0007914120786236 0.0 0.0 0.0 0.0 |
| Insulin processing 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Insulin receptor recycling 1.0 15.0 7.274170274170274 0.1375212864755611 0.0 0.0 0.0 0.0 |
| Insulin receptor signalling cascade 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integration of energy metabolism 0.0 71.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integration of provirus 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integrin cell surface interactions 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Integrin signaling 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interaction between l1 and ankyrins 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interaction with cumulus cells and the zona pellucida 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interactions of rev with host cellular proteins 1.0 37.0 2.822671156004489 0.3060304729743218 0.0 0.0 0.0 0.0 |
| Interactions of vpr with host cellular proteins 1.0 37.0 2.822671156004489 0.3060304729743218 0.0 0.0 0.0 0.0 |
| Interconversion of nucleotide di and triphosphates 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interferon alpha beta signaling 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interferon gamma signaling 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interferon signaling 1.0 128.0 0.7928895251729897 0.7190430615096002 0.0 0.0 0.0 0.0 |
| Interleukin 1 family signaling 1.0 95.0 1.0747904577691811 0.6096462186358106 0.0 0.0 0.0 0.0 |
| Interleukin 1 processing 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 1 signaling 1.0 82.0 1.248908841501434 0.5557866832475982 0.0 0.0 0.0 0.0 |
| Interleukin 10 signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 12 family signaling 1.0 43.0 2.417989417989418 0.3460310778663031 0.0 0.0 0.0 0.0 |
| Interleukin 12 signaling 1.0 38.0 2.746109746109746 0.3128615540599918 0.0 0.0 0.0 0.0 |
| Interleukin 15 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 17 signaling 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 2 family signaling 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 2 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 20 family signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 21 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 23 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 27 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 3 interleukin 5 and gm csf signaling 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 35 signalling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 36 pathway 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 37 signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 4 and interleukin 13 signaling 1.0 40.0 2.6047656047656047 0.3263246311566628 0.0 0.0 0.0 0.0 |
| Interleukin 6 family signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 6 signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 7 signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin 9 signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Interleukin receptor shc signaling 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intra golgi and retrograde golgi to er traffic 3.0 181.0 1.723271168770995 0.2618762982391017 0.0 0.0 0.0 0.0 |
| Intra golgi traffic 1.0 42.0 2.477211135747721 0.339526513295544 0.0 0.0 0.0 0.0 |
| Intracellular signaling by second messengers 1.0 233.0 0.4294670846394984 0.902035942728746 0.0 0.0 0.0 0.0 |
| Intraflagellar transport 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intrinsic pathway for apoptosis 0.0 53.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Intrinsic pathway of fibrin clot formation 1.0 7.0 10.0 0.0666860823201616 0.0 0.0 0.0 0.0 |
| Inwardly rectifying k channels 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ion channel transport 3.0 82.0 3.921571186219496 0.046481015474091 0.0 0.0 0.0 0.0 |
| Ion homeostasis 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ion transport by p type atpases 1.0 31.0 3.3892255892255894 0.2636091346473535 0.0 0.0 0.0 0.0 |
| Ionotropic activity of kainate receptors 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irak1 recruits ikk complex 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irak2 mediated activation of tak1 complex 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irak4 deficiency tlr2 4 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ire1alpha activates chaperones 2.0 44.0 4.885325558794946 0.0690620672163432 0.0 0.0 0.0 0.0 |
| Irf3 mediated activation of type 1 ifn 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irf3 mediated induction of type i ifn 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Iron uptake and transport 3.0 38.0 8.890427098674522 0.0060217503205503 0.0 0.0 0.0 0.0 |
| Irs activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Irs mediated signalling 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Jnk c jun kinases phosphorylation and activation mediated by activated human tak1 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Josephin domain dubs 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratan sulfate biosynthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratan sulfate degradation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratan sulfate keratin metabolism 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Keratinization 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ketone body metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Killing mechanisms 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Kinesins 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ksrp khsrp binds and destabilizes mrna 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| L1cam interactions 0.0 91.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lagging strand synthesis 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Laminin interactions 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Late endosomal microautophagy 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ldl clearance 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ldl remodeling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Leishmania infection 2.0 110.0 1.8873771730914588 0.2934964278814309 0.0 0.0 0.0 0.0 |
| Lgi adam interactions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ligand receptor interactions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Linoleic acid la metabolism 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lipid particle organization 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lipophagy 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Listeria monocytogenes entry into host cells 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Long term potentiation 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Loss of function of mecp2 in rett syndrome 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Loss of function of smad2 3 in cancer 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Loss of mecp2 binding ability to the ncor smrt complex 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lrr flii interacting protein 1 lrrfip1 activates type i ifn production 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lysine catabolism 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lysosome vesicle biogenesis 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Lysosphingolipid and lpa receptors 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| M phase 3.0 355.0 0.8561387066541706 0.6820060693437469 0.0 0.0 0.0 0.0 |
| Map2k and mapk activation 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Map3k8 tpl2 dependent mapk1 3 activation 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk family signaling cascades 2.0 212.0 0.9607385811467444 0.6193357810060641 0.0 0.0 0.0 0.0 |
| Mapk targets nuclear events mediated by map kinases 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk1 erk2 activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk3 erk1 activation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mapk6 mapk4 signaling 1.0 77.0 1.331738437001595 0.5331665625078387 0.0 0.0 0.0 0.0 |
| Mastl facilitates mitotic progression 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of protein 3a 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 1 nucleoprotein 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 1 spike protein 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 2 nucleoprotein 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Maturation of sars cov 2 spike protein 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mecp2 regulates neuronal receptors and channels 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mecp2 regulates transcription factors 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mecp2 regulates transcription of neuronal ligands 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Meiosis 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Meiotic recombination 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Meiotic synapsis 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Membrane trafficking 5.0 532.0 0.95565764506142 0.6033098758777323 0.0 0.0 0.0 0.0 |
| Met activates pi3k akt signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates ptk2 signaling 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates ptpn11 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates rap1 and rac1 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met activates ras signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met interacts with tns proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met promotes cell motility 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met receptor activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Met receptor recycling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolic disorders of biological oxidation enzymes 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of amine derived hormones 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of amino acids and derivatives 4.0 281.0 1.476985559566787 0.2972060015190551 0.0 0.0 0.0 0.0 |
| Metabolism of angiotensinogen to angiotensins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of carbohydrates 5.0 201.0 2.65843179377014 0.0474718241001113 0.0 0.0 0.0 0.0 |
| Metabolism of cofactors 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of fat soluble vitamins 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of folate and pterines 1.0 15.0 7.274170274170274 0.1375212864755611 0.0 0.0 0.0 0.0 |
| Metabolism of ingested semet sec mesec into h2se 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of lipids 16.0 508.0 3.718157181571816 3.149686494044042e-05 0.0 0.0 0.0 0.0 |
| Metabolism of nitric oxide nos3 activation and regulation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of nucleotides 0.0 82.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of polyamines 1.0 48.0 2.1596819256393727 0.3776146865857887 0.0 0.0 0.0 0.0 |
| Metabolism of porphyrins 2.0 17.0 10.0 0.0117676307173903 0.0 0.0 0.0 0.0 |
| Metabolism of rna 3.0 647.0 0.4539284113466094 0.9573471851133816 0.0 0.0 0.0 0.0 |
| Metabolism of steroid hormones 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metabolism of steroids 4.0 103.0 4.207491582491582 0.0183908054706022 0.0 0.0 0.0 0.0 |
| Metabolism of vitamins and cofactors 1.0 134.0 0.7566643882433356 0.7353802816028594 0.0 0.0 0.0 0.0 |
| Metabolism of water soluble vitamins and cofactors 1.0 91.0 1.1230078563411896 0.5938019181425528 0.0 0.0 0.0 0.0 |
| Metal ion slc transporters 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metalloprotease dubs 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Metallothioneins bind metals 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Methionine salvage pathway 1.0 6.0 10.0 0.0574361921538736 0.0 0.0 0.0 0.0 |
| Methylation 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mhc class ii antigen presentation 1.0 100.0 1.0199979593918989 0.6285936102034135 0.0 0.0 0.0 0.0 |
| Microrna mirna biogenesis 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Miro gtpase cycle 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Miscellaneous substrates 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Miscellaneous transport and binding events 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mismatch repair 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial biogenesis 2.0 85.0 2.462011310548316 0.2027827245191691 0.0 0.0 0.0 0.0 |
| Mitochondrial calcium ion transport 2.0 21.0 10.0 0.0177148463510605 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation of saturated fatty acids 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial fatty acid beta oxidation of unsaturated fatty acids 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial iron sulfur cluster biogenesis 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial protein import 6.0 59.0 10.0 2.2653824984110294e-05 0.0 0.0 0.0 0.0 |
| Mitochondrial translation 0.0 93.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial trna aminoacylation 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitochondrial uncoupling 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitophagy 3.0 24.0 10.0 0.0015953295223005 0.0 0.0 0.0 0.0 |
| Mitotic g1 phase and g1 s transition 1.0 143.0 0.708066581306018 0.7581385700495896 0.0 0.0 0.0 0.0 |
| Mitotic g2 g2 m phases 1.0 186.0 0.5411411411411411 0.8427895593060013 0.0 0.0 0.0 0.0 |
| Mitotic metaphase and anaphase 3.0 225.0 1.375592086932293 0.3799519290651801 0.0 0.0 0.0 0.0 |
| Mitotic prometaphase 0.0 198.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitotic prophase 1.0 93.0 1.098375054896794 0.6018020784024207 0.0 0.0 0.0 0.0 |
| Mitotic spindle checkpoint 0.0 111.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mitotic telophase cytokinesis 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Modulation by mtb of host immune system 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Molecules associated with elastic fibres 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Molybdenum cofactor biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna capping 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna decay by 3 to 5 exoribonuclease 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna decay by 5 to 3 exoribonuclease 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna editing 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna editing c to u conversion 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mrna splicing 1.0 188.0 0.5352455031599417 0.8459150927506387 0.0 0.0 0.0 0.0 |
| Mrna splicing minor pathway 0.0 52.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mtor signalling 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mtorc1 mediated signalling 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Mucopolysaccharidoses 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Multifunctional anion exchangers 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Muscle contraction 0.0 83.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Myd88 independent tlr4 cascade 0.0 78.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Myoclonic epilepsy of lafora 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Myogenesis 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan antennae elongation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan antennae elongation in the medial trans golgi 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan trimming and elongation in the cis golgi 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| N glycan trimming in the er and calnexin calreticulin cycle 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Na cl dependent neurotransmitter transporters 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nade modulates death signalling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ncam signaling for neurite out growth 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ncam1 interactions 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nectin necl trans heterodimerization 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neddylation 1.0 185.0 0.544137022397892 0.8412033375239305 0.0 0.0 0.0 0.0 |
| Nef and signal transduction 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated cd4 down regulation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated cd8 down regulation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediated downregulation of mhc class i complex cell surface expression 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nef mediates down modulation of cell surface receptors by recruiting them to clathrin adapters 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative epigenetic regulation of rrna expression 0.0 61.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative feedback regulation of mapk pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of activity of tfap2 ap 2 family transcription factors 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr1 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr2 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr3 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of fgfr4 signaling 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of flt3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of mapk pathway 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of met activity 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of nmda receptor mediated neuronal transmission 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of notch4 signaling 1.0 49.0 2.114478114478114 0.3837477700803094 0.0 0.0 0.0 0.0 |
| Negative regulation of tcf dependent signaling by dvl interacting proteins 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of tcf dependent signaling by wnt ligand antagonists 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulation of the pi3k akt network 0.0 62.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Negative regulators of ddx58 ifih1 signaling 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nephrin family interactions 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nervous system development 3.0 443.0 0.6787253983130271 0.8159339945350605 0.0 0.0 0.0 0.0 |
| Netrin 1 signaling 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Netrin mediated repulsion signals 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurexins and neuroligins 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurofascin interactions 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neuronal system 1.0 177.0 0.5693296602387512 0.8279298633693734 0.0 0.0 0.0 0.0 |
| Neurotoxicity of clostridium toxins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurotransmitter clearance 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurotransmitter receptors and postsynaptic signal transmission 0.0 105.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neurotransmitter release cycle 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Neutrophil degranulation 6.0 319.0 1.9950377268710489 0.0931598622681849 0.0 0.0 0.0 0.0 |
| Nf kb activation through fadd rip 1 pathway mediated by caspase 8 and 10 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nf kb is activated and signals survival 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ngf independant trka activation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ngf stimulated transcription 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nicotinamide salvaging 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nicotinate metabolism 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nitric oxide stimulates guanylate cyclase 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nod1 2 signaling pathway 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Non integrin membrane ecm interactions 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Noncanonical activation of notch3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nonhomologous end joining nhej 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nonsense mediated decay nmd 0.0 110.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Norepinephrine neurotransmitter release cycle 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nostrin mediated enos trafficking 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch hlh transcription pathway 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch1 intracellular domain regulates transcription 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch2 activation and transmission of signal to the nucleus 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch2 intracellular domain regulates transcription 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch3 activation and transmission of signal to the nucleus 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch3 intracellular domain regulates transcription 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch4 activation and transmission of signal to the nucleus 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Notch4 intracellular domain regulates transcription 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 and nr1h3 mediated signaling 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to gluconeogenesis 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to lipogenesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression linked to triglyceride lipolysis in adipose 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression to control bile acid homeostasis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h2 nr1h3 regulate gene expression to limit cholesterol uptake 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nr1h3 nr1h2 regulate gene expression linked to cholesterol transport and efflux 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nrage signals death through jnk 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nrcam interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nrif signals cell death from the nucleus 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ns1 mediated effects on host pathways 1.0 40.0 2.6047656047656047 0.3263246311566628 0.0 0.0 0.0 0.0 |
| Ntrk2 activates rac1 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear envelope breakdown 1.0 54.0 1.914046121593292 0.4135270958140081 0.0 0.0 0.0 0.0 |
| Nuclear envelope ne reassembly 2.0 71.0 2.9656906240757173 0.1536294983436044 0.0 0.0 0.0 0.0 |
| Nuclear events kinase and transcription factor activation 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear events stimulated by alk signaling in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear import of rev protein 1.0 34.0 3.0801958983777165 0.2851312580635185 0.0 0.0 0.0 0.0 |
| Nuclear pore complex npc disassembly 1.0 36.0 2.903607503607504 0.299132167535026 0.0 0.0 0.0 0.0 |
| Nuclear receptor transcription pathway 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nuclear signaling by erbb4 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide binding domain leucine rich repeat containing receptor nlr signaling pathways 1.0 42.0 2.477211135747721 0.339526513295544 0.0 0.0 0.0 0.0 |
| Nucleotide biosynthesis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide catabolism 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide excision repair 0.0 114.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide like purinergic receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Nucleotide salvage 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| O glycosylation of tsr domain containing proteins 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| O linked glycosylation 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| O linked glycosylation of mucins 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oas antiviral response 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Olfactory signaling pathway 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oncogene induced senescence 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oncogenic mapk signaling 1.0 66.0 1.5588189588189587 0.4793101444108065 0.0 0.0 0.0 0.0 |
| Opioid signalling 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Orc1 removal from chromatin 1.0 65.0 1.5833333333333333 0.4741193373633443 0.0 0.0 0.0 0.0 |
| Organelle biogenesis and maintenance 3.0 268.0 1.1473643260066135 0.4915345323449248 0.0 0.0 0.0 0.0 |
| Organic anion transporters 1.0 3.0 10.0 0.0291384996647827 0.0 0.0 0.0 0.0 |
| Organic cation anion zwitterion transport 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Organic cation transport 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Other interleukin signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Other semaphorin interactions 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ovarian tumor domain proteases 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Oxidative stress induced senescence 0.0 69.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P130cas linkage to mapk signaling for integrins 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P2y receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P38mapk events 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75 ntr receptor mediated signalling 1.0 81.0 1.2646464646464646 0.5513512032975088 0.0 0.0 0.0 0.0 |
| P75ntr negatively regulates cell cycle via sc1 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75ntr recruits signalling complexes 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| P75ntr regulates axonogenesis 1.0 5.0 10.0 0.0480955538847994 0.0 0.0 0.0 0.0 |
| P75ntr signals via nf kb 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Parasite infection 1.0 50.0 2.0711193568336426 0.3898210156705143 0.0 0.0 0.0 0.0 |
| Passive transport by aquaporins 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pcna dependent long patch base excision repair 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pcp ce pathway 1.0 78.0 1.3143119506755871 0.5377799970023095 0.0 0.0 0.0 0.0 |
| Pd 1 signaling 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pecam1 interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pentose phosphate pathway 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Peptide hormone metabolism 1.0 43.0 2.417989417989418 0.3460310778663031 0.0 0.0 0.0 0.0 |
| Peptide ligand binding receptors 2.0 17.0 10.0 0.0117676307173903 0.0 0.0 0.0 0.0 |
| Perk regulates gene expression 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Peroxisomal lipid metabolism 1.0 24.0 4.423803249890207 0.2108642126213972 0.0 0.0 0.0 0.0 |
| Peroxisomal protein import 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pexophagy 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 0 rapid depolarisation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 2 plateau phase 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 3 rapid repolarisation 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase 4 resting membrane potential 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phase i functionalization of compounds 3.0 39.0 8.642611683848797 0.006477682080963 0.0 0.0 0.0 0.0 |
| Phase ii conjugation of compounds 1.0 53.0 1.951048951048951 0.4076874771235006 0.0 0.0 0.0 0.0 |
| Phenylalanine and tyrosine metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phenylalanine metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphate bond hydrolysis by ntpdase proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphate bond hydrolysis by nudt proteins 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipase c mediated cascade fgfr2 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipase c mediated cascade fgfr4 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phospholipid metabolism 3.0 156.0 2.009904992925005 0.1971826376931648 0.0 0.0 0.0 0.0 |
| Phosphorylation of emi1 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Phosphorylation of the apc c 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Physiological factors 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr2 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi 3k cascade fgfr4 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi metabolism 0.0 71.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi3k akt activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi3k akt signaling in cancer 0.0 58.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi3k events in erbb2 signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi3k events in erbb4 signaling 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pi5p regulates tp53 acetylation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pink1 prkn mediated mitophagy 3.0 17.0 10.0 0.0005633424812776 0.0 0.0 0.0 0.0 |
| Piwi interacting rna pirna biogenesis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pka activation in glucagon signalling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pka mediated phosphorylation of creb 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pka mediated phosphorylation of key metabolic factors 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pkmts methylate histone lysines 0.0 46.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein assembly 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein assembly remodeling and clearance 1.0 40.0 2.6047656047656047 0.3263246311566628 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein clearance 1.0 23.0 4.62534435261708 0.2030300441679912 0.0 0.0 0.0 0.0 |
| Plasma lipoprotein remodeling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet activation signaling and aggregation 1.0 152.0 0.6652618904274533 0.7789574534058219 0.0 0.0 0.0 0.0 |
| Platelet adhesion to exposed collagen 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet aggregation plug formation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet calcium homeostasis 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet homeostasis 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Platelet sensitization by ldl 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polb dependent long patch base excision repair 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polo like kinase mediated events 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polymerase switching 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Polymerase switching on the c strand of the telomere 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Positive epigenetic regulation of rrna expression 0.0 60.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Post chaperonin tubulin folding pathway 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Post translational modification synthesis of gpi anchored proteins 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Post translational protein modification 8.0 1003.0 0.7953681450731921 0.7799050681284141 0.0 0.0 0.0 0.0 |
| Postmitotic nuclear pore complex npc reformation 1.0 27.0 3.912198912198912 0.2339121686337894 0.0 0.0 0.0 0.0 |
| Potassium channels 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Potential therapeutics for sars 1.0 68.0 1.5119855269109 0.4895400608205746 0.0 0.0 0.0 0.0 |
| Pou5f1 oct4 sox2 nanog activate genes related to proliferation 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pou5f1 oct4 sox2 nanog repress genes related to differentiation 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pp2a mediated dephosphorylation of key metabolic factors 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prc2 methylates histones and dna 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pre notch expression and processing 0.0 50.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pre notch processing in golgi 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pre notch processing in the endoplasmic reticulum 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pregnenolone biosynthesis 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Presynaptic depolarization and calcium channel opening 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Presynaptic function of kainate receptors 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Presynaptic nicotinic acetylcholine receptors 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prevention of phagosomal lysosomal fusion 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing and activation of sumo 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of capped intron containing pre mrna 2.0 239.0 0.8489623697580297 0.6842368517773473 0.0 0.0 0.0 0.0 |
| Processing of capped intronless pre mrna 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of dna double strand break ends 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of intronless pre mrnas 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processing of smdt1 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processive synthesis on the c strand of the telomere 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Processive synthesis on the lagging strand 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Programmed cell death 1.0 179.0 0.5628192032686414 0.8313477677603678 0.0 0.0 0.0 0.0 |
| Prolactin receptor signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prolonged erk activation events 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Propionyl coa catabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Prostacyclin signalling through prostacyclin receptor 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein folding 1.0 79.0 1.2973322973322974 0.5423482911753763 0.0 0.0 0.0 0.0 |
| Protein localization 10.0 142.0 8.387205387205388 1.1888271395787942e-06 0.0 0.0 0.0 0.0 |
| Protein methylation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein protein interactions at synapses 1.0 46.0 2.2561167227833896 0.3651666660190783 0.0 0.0 0.0 0.0 |
| Protein repair 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Protein ubiquitination 0.0 58.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Proton coupled monocarboxylate transport 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pten regulation 1.0 128.0 0.7928895251729897 0.7190430615096002 0.0 0.0 0.0 0.0 |
| Ptk6 expression 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 promotes hif1a stabilization 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates cell cycle 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates proteins involved in rna processing 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates rho gtpases ras gtpase and map kinases 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ptk6 regulates rtks and their effectors akt1 and dok1 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine catabolism 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine ribonucleoside monophosphate biosynthesis 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purine salvage 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Purinergic signaling in leishmaniasis infection 1.0 12.0 9.26078971533517 0.1116045715736199 0.0 0.0 0.0 0.0 |
| Pyrimidine catabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyrimidine salvage 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyroptosis 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Pyruvate metabolism 1.0 26.0 4.069090909090909 0.2263045436956677 0.0 0.0 0.0 0.0 |
| Pyruvate metabolism and citric acid tca cycle 1.0 48.0 2.1596819256393727 0.3776146865857887 0.0 0.0 0.0 0.0 |
| Ra biosynthesis pathway 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rab gefs exchange gtp for gdp on rabs 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rab geranylgeranylation 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rab regulation of trafficking 0.0 107.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rac1 gtpase cycle 1.0 152.0 0.6652618904274533 0.7789574534058219 0.0 0.0 0.0 0.0 |
| Rac2 gtpase cycle 3.0 81.0 3.972244250594766 0.0450913351422118 0.0 0.0 0.0 0.0 |
| Rac3 gtpase cycle 2.0 83.0 2.5233056185437137 0.195637464602177 0.0 0.0 0.0 0.0 |
| Raf activation 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Raf independent mapk1 3 activation 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rap1 signalling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ras activation upon ca2 influx through nmda receptor 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ras processing 1.0 19.0 5.6554433221099885 0.1709159600444602 0.0 0.0 0.0 0.0 |
| Ras signaling downstream of nf1 loss of function variants 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reactions specific to the complex n glycan synthesis pathway 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Receptor mediated mitophagy 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Receptor type tyrosine protein phosphatases 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recognition and association of dna glycosylase with site containing an affected purine 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recognition of dna damage by pcna containing replication complex 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recruitment of mitotic centrosome proteins and complexes 0.0 82.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recruitment of numa to mitotic centrosomes 0.0 90.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recycling of bile acids and salts 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recycling of eif2 gdp 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Recycling pathway of l1 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reduction of cytosolic ca levels 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reelin signalling pathway 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulated necrosis 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulated proteolysis of p75ntr 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation by c flip 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of bach1 activity 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of beta cell development 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of cholesterol biosynthesis by srebp srebf 1.0 55.0 1.878413767302656 0.4193097117028734 0.0 0.0 0.0 0.0 |
| Regulation of commissural axon pathfinding by slit and robo 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of cytoskeletal remodeling and cell spreading by ipp complex components 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of expression of slits and robos 1.0 155.0 0.6521054702872885 0.7854948095091228 0.0 0.0 0.0 0.0 |
| Regulation of foxo transcriptional activity by acetylation 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of fzd by ubiquitination 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression by hypoxia inducible factor 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in beta cells 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in early pancreatic precursor cells 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of gene expression in late stage branching morphogenesis pancreatic bud precursor cells 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of glucokinase by glucokinase regulatory protein 1.0 31.0 3.3892255892255894 0.2636091346473535 0.0 0.0 0.0 0.0 |
| Regulation of glycolysis by fructose 2 6 bisphosphate metabolism 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of hmox1 expression and activity 2.0 58.0 3.6588921282798834 0.1106573079891401 0.0 0.0 0.0 0.0 |
| Regulation of hsf1 mediated heat shock response 1.0 76.0 1.3496296296296295 0.5285075461630524 0.0 0.0 0.0 0.0 |
| Regulation of ifna signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of ifng signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of innate immune responses to cytosolic dna 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of insulin like growth factor igf transport and uptake by insulin like growth factor binding proteins igfbps 1.0 56.0 1.844077134986226 0.4250358756773005 0.0 0.0 0.0 0.0 |
| Regulation of insulin secretion 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of kit signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of lipid metabolism by pparalpha 1.0 95.0 1.0747904577691811 0.6096462186358106 0.0 0.0 0.0 0.0 |
| Regulation of localization of foxo transcription factors 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of mecp2 expression and activity 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of mrna stability by proteins that bind au rich elements 1.0 79.0 1.2973322973322974 0.5423482911753763 0.0 0.0 0.0 0.0 |
| Regulation of plk1 activity at g2 m transition 0.0 87.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten gene transcription 0.0 56.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten localization 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten mrna translation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of pten stability and activity 1.0 63.0 1.634734441186054 0.4635835476922714 0.0 0.0 0.0 0.0 |
| Regulation of pyruvate dehydrogenase pdh complex 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of ras by gaps 1.0 57.0 1.810966810966811 0.4307061333231872 0.0 0.0 0.0 0.0 |
| Regulation of runx1 expression and activity 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of runx2 expression and activity 1.0 61.0 1.6895622895622897 0.4528388306838392 0.0 0.0 0.0 0.0 |
| Regulation of runx3 expression and activity 1.0 52.0 1.989502871855813 0.4017902994798545 0.0 0.0 0.0 0.0 |
| Regulation of signaling by cbl 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of signaling by nodal 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tlr by endogenous ligand 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tnfr1 signaling 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity 0.0 146.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through acetylation 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through association with co factors 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through methylation 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 activity through phosphorylation 0.0 82.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Regulation of tp53 expression and degradation 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Release of apoptotic factors from the mitochondria 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Release of hh np from the secreting cell 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Removal of aminoterminal propeptides from gamma carboxylated proteins 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Repression of wnt target genes 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reproduction 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of abasic sites ap sites 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of ap sites via the multiple nucleotide patch replacement pathway 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of d loop structures 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of d loop structures through synthesis dependent strand annealing sdsa 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Resolution of sister chromatid cohesion 0.0 120.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Respiratory electron transport 4.0 101.0 4.295103092783505 0.0172354677097154 0.0 0.0 0.0 0.0 |
| Respiratory electron transport atp synthesis by chemiosmotic coupling and heat production by uncoupling proteins 5.0 116.0 4.734471313418682 0.0055802593941936 0.0 0.0 0.0 0.0 |
| Response of eif2ak1 hri to heme deficiency 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Response of eif2ak4 gcn2 to amino acid deficiency 0.0 94.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Response of mtb to phagocytosis 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Response to elevated platelet cytosolic ca2 1.0 71.0 1.446753246753247 0.5045129832066302 0.0 0.0 0.0 0.0 |
| Response to metal ions 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ret signaling 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Retinoid cycle disease events 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Retrograde neurotrophin signalling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Retrograde transport at the trans golgi network 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Reversible hydration of carbon dioxide 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpase cycle 6.0 387.0 1.627575808343106 0.1793986623830951 0.0 0.0 0.0 0.0 |
| Rho gtpase effectors 1.0 246.0 0.4061430632859204 0.9140832188691884 0.0 0.0 0.0 0.0 |
| Rho gtpases activate cit 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate formins 0.0 133.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate iqgaps 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate ktn1 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate nadph oxidases 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate paks 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate pkns 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate rhotekin and rhophilins 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate rocks 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rho gtpases activate wasps and waves 1.0 33.0 3.176767676767677 0.2780273254227372 0.0 0.0 0.0 0.0 |
| Rhoa gtpase cycle 2.0 134.0 1.5405071119356837 0.3794730020368597 0.0 0.0 0.0 0.0 |
| Rhob gtpase cycle 0.0 69.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhobtb gtpase cycle 0.0 33.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhobtb1 gtpase cycle 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhobtb2 gtpase cycle 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhobtb3 atpase cycle 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoc gtpase cycle 0.0 75.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhod gtpase cycle 1.0 50.0 2.0711193568336426 0.3898210156705143 0.0 0.0 0.0 0.0 |
| Rhof gtpase cycle 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhog gtpase cycle 2.0 71.0 2.9656906240757173 0.1536294983436044 0.0 0.0 0.0 0.0 |
| Rhoh gtpase cycle 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoj gtpase cycle 0.0 55.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhoq gtpase cycle 0.0 59.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhot1 gtpase cycle 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhou gtpase cycle 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rhov gtpase cycle 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rip mediated nfkb activation via zbp1 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ripk1 mediated regulated necrosis 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rmts methylate histone arginines 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase i promoter escape 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription initiation 0.0 49.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase i transcription termination 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcribes snrna genes 0.0 73.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcription 1.0 969.0 0.0952500208698555 0.9999562705029896 0.0 0.0 0.0 0.0 |
| Rna polymerase ii transcription termination 0.0 66.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii chain elongation 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription 0.0 44.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription initiation from type 1 promoter 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription initiation from type 3 promoter 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rna polymerase iii transcription termination 0.0 24.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rnd1 gtpase cycle 1.0 36.0 2.903607503607504 0.299132167535026 0.0 0.0 0.0 0.0 |
| Rnd2 gtpase cycle 1.0 40.0 2.6047656047656047 0.3263246311566628 0.0 0.0 0.0 0.0 |
| Rnd3 gtpase cycle 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Robo receptors bind akap5 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of abl in robo slit signaling 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of lat2 ntal lab on calcium mobilization 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Role of phospholipids in phagocytosis 1.0 16.0 6.788552188552188 0.1459927402947744 0.0 0.0 0.0 0.0 |
| Role of second messengers in netrin 1 signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rora activates gene expression 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ros and rns production in phagocytes 1.0 16.0 6.788552188552188 0.1459927402947744 0.0 0.0 0.0 0.0 |
| Rrna modification in the mitochondrion 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rrna modification in the nucleus and cytosol 0.0 63.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rrna processing 0.0 202.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rrna processing in the mitochondrion 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Rsk activation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 and foxp3 control the development of regulatory t lymphocytes tregs 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 interacts with co factors whose precise effect on runx1 targets is not known 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates estrogen receptor mediated transcription 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates expression of components of tight junctions 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates genes involved in megakaryocyte differentiation and platelet function 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in bcr signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of hscs 1.0 68.0 1.5119855269109 0.4895400608205746 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of keratinocytes 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in differentiation of myeloid cells 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in interleukin signaling 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx1 regulates transcription of genes involved in wnt signaling 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates bone development 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates chondrocyte maturation 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates genes involved in cell migration 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx2 regulates osteoblast differentiation 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates bcl2l11 bim transcription 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates cdkn1a transcription 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates immune response and cell migration 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates notch signaling 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates p14 arf 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates wnt signaling 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Runx3 regulates yap1 mediated transcription 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| S phase 1.0 158.0 0.6394518432734994 0.7918406993472096 0.0 0.0 0.0 0.0 |
| Sars cov 1 infection 0.0 42.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sars cov 2 infection 0.0 62.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sars cov infections 1.0 128.0 0.7928895251729897 0.7190430615096002 0.0 0.0 0.0 0.0 |
| Scavenging by class a receptors 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scavenging by class b receptors 1.0 2.0 10.0 0.0195202957776364 0.0 0.0 0.0 0.0 |
| Scavenging by class f receptors 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scavenging of heme from plasma 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Scf skp2 mediated degradation of p27 p21 1.0 54.0 1.914046121593292 0.4135270958140081 0.0 0.0 0.0 0.0 |
| Sealing of the nuclear envelope ne by escrt iii 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Selective autophagy 3.0 67.0 4.847938144329897 0.0279020879533615 0.0 0.0 0.0 0.0 |
| Selenoamino acid metabolism 0.0 107.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema3a pak dependent axon repulsion 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema3a plexin repulsion signaling by inhibiting integrin adhesion 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema4d in semaphorin signaling 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema4d induced cell migration and growth cone collapse 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sema4d mediated inhibition of cell attachment and migration 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Semaphorin interactions 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Senescence associated secretory phenotype sasp 0.0 54.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensing of dna double strand breaks 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory perception 0.0 84.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory perception of taste 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory processing of sound 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sensory processing of sound by outer hair cells of the cochlea 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Separation of sister chromatids 1.0 179.0 0.5628192032686414 0.8313477677603678 0.0 0.0 0.0 0.0 |
| Serine biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Serotonin neurotransmitter release cycle 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr1 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr3 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc mediated cascade fgfr4 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc related events triggered by igf1r 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in egfr signaling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in erbb2 signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Shc1 events in erbb4 signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sialic acid metabolism 1.0 16.0 6.788552188552188 0.1459927402947744 0.0 0.0 0.0 0.0 |
| Signal amplification 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal attenuation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal regulatory protein family interactions 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signal transduction by l1 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by activin 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by alk 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by alk in cancer 0.0 52.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by bmp 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by braf and raf1 fusions 1.0 53.0 1.951048951048951 0.4076874771235006 0.0 0.0 0.0 0.0 |
| Signaling by csf3 g csf 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ctnnb1 phospho site mutants 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by cytosolic fgfr1 fusion mutants 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by egfr 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by egfr in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 ecd mutants 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb2 in cancer 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erbb4 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by erythropoietin 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr 0.0 57.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr in disease 0.0 48.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr1 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr1 in disease 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 iiia tm 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr2 in disease 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr3 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr3 fusions in cancer 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr4 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by fgfr4 in disease 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by flt3 fusion proteins 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by flt3 itd and tkd mutants 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by gpcr 2.0 204.0 0.9995958779551424 0.5982637837269607 0.0 0.0 0.0 0.0 |
| Signaling by hedgehog 1.0 122.0 0.8327072376659154 0.7017079055797242 0.0 0.0 0.0 0.0 |
| Signaling by hippo 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by insulin receptor 1.0 45.0 2.307621671258035 0.3588505448912167 0.0 0.0 0.0 0.0 |
| Signaling by interleukins 3.0 248.0 1.2435514411950348 0.4406224335053858 0.0 0.0 0.0 0.0 |
| Signaling by kit in disease 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by leptin 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by lrp5 mutants 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by mapk mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by membrane tethered fusions of pdgfra or pdgfrb 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by met 0.0 64.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by moderate kinase activity braf mutants 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by mras complex mutants 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by mst1 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by nodal 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch 1.0 152.0 0.6652618904274533 0.7789574534058219 0.0 0.0 0.0 0.0 |
| Signaling by notch1 0.0 56.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch1 hd domain mutants in cancer 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch1 pest domain mutants in cancer 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch1 t 7 9 notch1 m1580 k2555 translocation mutant 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch2 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch3 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by notch4 1.0 71.0 1.446753246753247 0.5045129832066302 0.0 0.0 0.0 0.0 |
| Signaling by ntrk2 trkb 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ntrk3 trkc 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ntrks 0.0 102.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by nuclear receptors 0.0 178.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by pdgf 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by pdgfr in disease 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by pdgfra transmembrane juxtamembrane and kinase domain mutants 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by ptk6 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by receptor tyrosine kinases 2.0 344.0 0.5820503640052512 0.856163678469903 0.0 0.0 0.0 0.0 |
| Signaling by retinoic acid 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by rho gtpases miro gtpases and rhobtb3 6.0 593.0 1.0339990575954183 0.5290177338622842 0.0 0.0 0.0 0.0 |
| Signaling by rnf43 mutants 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by robo receptors 1.0 197.0 0.5102040816326531 0.8592356639539558 0.0 0.0 0.0 0.0 |
| Signaling by scf kit 0.0 31.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by tgf beta receptor complex 0.0 67.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by tgf beta receptor complex in cancer 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by tgfb family members 0.0 79.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by the b cell receptor bcr 1.0 91.0 1.1230078563411896 0.5938019181425528 0.0 0.0 0.0 0.0 |
| Signaling by type 1 insulin like growth factor 1 receptor igf1r 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signaling by vegf 1.0 87.0 1.1757105943152455 0.5773211926082669 0.0 0.0 0.0 0.0 |
| Signaling by wnt 1.0 213.0 0.4709357728225652 0.8801615941747158 0.0 0.0 0.0 0.0 |
| Signaling by wnt in cancer 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signalling to erks 0.0 30.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signalling to p38 via rit and rin 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Signalling to ras 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sirt1 negatively regulates rrna expression 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Slbp dependent processing of replication dependent histone pre mrnas 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Slc mediated transmembrane transport 3.0 101.0 3.155270355564906 0.0767446240128207 0.0 0.0 0.0 0.0 |
| Slc transporter disorders 1.0 54.0 1.914046121593292 0.4135270958140081 0.0 0.0 0.0 0.0 |
| Smac xiap regulated apoptotic response 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Smad2 smad3 smad4 heterotrimer regulates transcription 0.0 29.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Small interfering rna sirna biogenesis 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Smooth muscle contraction 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Snrnp assembly 1.0 53.0 1.951048951048951 0.4076874771235006 0.0 0.0 0.0 0.0 |
| Sodium calcium exchangers 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sodium coupled phosphate cotransporters 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sodium proton exchangers 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sos mediated signalling 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sperm motility and taxes 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sphingolipid de novo biosynthesis 2.0 29.0 7.610733182161754 0.0325598174288622 0.0 0.0 0.0 0.0 |
| Sphingolipid metabolism 6.0 62.0 10.0 3.0184002389216613e-05 0.0 0.0 0.0 0.0 |
| Spry regulation of fgf signaling 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Srp dependent cotranslational protein targeting to membrane 3.0 108.0 2.942857142857143 0.0896229662502218 0.0 0.0 0.0 0.0 |
| Stabilization of p53 1.0 51.0 2.029494949494949 0.3958350013250431 0.0 0.0 0.0 0.0 |
| Stat3 nuclear events downstream of alk signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stat5 activation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stat5 activation downstream of flt3 itd mutants 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Stimuli sensing channels 1.0 38.0 2.746109746109746 0.3128615540599918 0.0 0.0 0.0 0.0 |
| Sting mediated induction of host immune responses 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Striated muscle contraction 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sulfide oxidation to sulfate 1.0 5.0 10.0 0.0480955538847994 0.0 0.0 0.0 0.0 |
| Sulfur amino acid metabolism 2.0 22.0 10.0 0.0193632099375005 0.0 0.0 0.0 0.0 |
| Sumo is conjugated to e1 uba2 sae1 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumo is proteolytically processed 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumo is transferred from e1 to e2 ube2i ubc9 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation 1.0 155.0 0.6521054702872885 0.7854948095091228 0.0 0.0 0.0 0.0 |
| Sumoylation of chromatin organization proteins 1.0 58.0 1.7790182527024632 0.4363210249842685 0.0 0.0 0.0 0.0 |
| Sumoylation of dna damage response and repair proteins 1.0 76.0 1.3496296296296295 0.5285075461630524 0.0 0.0 0.0 0.0 |
| Sumoylation of dna methylation proteins 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of dna replication proteins 1.0 46.0 2.2561167227833896 0.3651666660190783 0.0 0.0 0.0 0.0 |
| Sumoylation of immune response proteins 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of intracellular receptors 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of rna binding proteins 1.0 47.0 2.206851119894598 0.3714211816154574 0.0 0.0 0.0 0.0 |
| Sumoylation of sumoylation proteins 1.0 35.0 2.989304812834225 0.2921659829416722 0.0 0.0 0.0 0.0 |
| Sumoylation of transcription cofactors 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of transcription factors 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Sumoylation of ubiquitinylation proteins 1.0 39.0 2.6735778841042 0.3196260593385788 0.0 0.0 0.0 0.0 |
| Suppression of apoptosis 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Suppression of phagosomal maturation 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Surfactant metabolism 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Switching of origins to a post replicative state 1.0 85.0 1.203944203944204 0.5688343041108967 0.0 0.0 0.0 0.0 |
| Synaptic adhesion like molecules 1.0 11.0 10.0 0.1027954944442906 0.0 0.0 0.0 0.0 |
| Syndecan interactions 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 12 eicosatetraenoic acid derivatives 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 15 eicosatetraenoic acid derivatives 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 16 20 hydroxyeicosatetraenoic acids hete 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of 5 eicosatetraenoic acids 1.0 3.0 10.0 0.0291384996647827 0.0 0.0 0.0 0.0 |
| Synthesis of active ubiquitin roles of e1 and e2 enzymes 0.0 26.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 24 hydroxycholesterol 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 27 hydroxycholesterol 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of bile acids and bile salts via 7alpha hydroxycholesterol 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of diphthamide eef2 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of dna 1.0 117.0 0.869035179380007 0.6864562302095232 0.0 0.0 0.0 0.0 |
| Synthesis of dolichyl phosphate 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of epoxy eet and dihydroxyeicosatrienoic acids dhet 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of gdp mannose 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of glycosylphosphatidylinositol gpi 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ip2 ip and ins in the cytosol 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ip3 and ip4 in the cytosol 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of ketone bodies 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of leukotrienes lt and eoxins ex 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of lipoxins lx 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pa 1.0 25.0 4.239057239057239 0.2186221342412543 0.0 0.0 0.0 0.0 |
| Synthesis of pc 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pe 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pg 1.0 8.0 10.0 0.0758460972151271 0.0 0.0 0.0 0.0 |
| Synthesis of pi 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the early endosome membrane 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the er membrane 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the golgi membrane 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the late endosome membrane 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pips at the plasma membrane 0.0 47.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of prostaglandins pg and thromboxanes tx 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of pyrophosphates in the cytosol 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of substrates in n glycan biosythesis 1.0 44.0 2.361522198731501 0.3524722176470324 0.0 0.0 0.0 0.0 |
| Synthesis of udp n acetyl glucosamine 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of very long chain fatty acyl coas 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis of wybutosine at g37 of trna phe 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Synthesis secretion and deacylation of ghrelin 1.0 5.0 10.0 0.0480955538847994 0.0 0.0 0.0 0.0 |
| Synthesis secretion and inactivation of glucagon like peptide 1 glp 1 1.0 12.0 9.26078971533517 0.1116045715736199 0.0 0.0 0.0 0.0 |
| Synthesis secretion and inactivation of glucose dependent insulinotropic polypeptide gip 1.0 9.0 10.0 0.0849171013653387 0.0 0.0 0.0 0.0 |
| Tak1 activates nfkb by phosphorylation and activation of ikks complex 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tandem pore domain potassium channels 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tbc rabgaps 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tcf dependent signaling in response to wnt 1.0 142.0 0.7131599684791174 0.7557087787032648 0.0 0.0 0.0 0.0 |
| Tcr signaling 1.0 85.0 1.203944203944204 0.5688343041108967 0.0 0.0 0.0 0.0 |
| Telomere c strand lagging strand synthesis 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Telomere c strand synthesis initiation 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Telomere extension by telomerase 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Telomere maintenance 0.0 74.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Terminal pathway of complement 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Termination of o glycan biosynthesis 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Termination of translesion dna synthesis 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tetrahydrobiopterin bh4 synthesis recycling salvage and regulation 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tfap2 ap 2 family regulates transcription of cell cycle factors 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tfap2 ap 2 family regulates transcription of growth factors and their receptors 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tfap2a acts as a transcriptional repressor during retinoic acid induced cell differentiation 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tgf beta receptor signaling activates smads 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tgf beta receptor signaling in emt epithelial to mesenchymal transition 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The activation of arylsulfatases 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The canonical retinoid cycle in rods twilight vision 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The citric acid tca cycle and respiratory electron transport 6.0 160.0 4.120751588836695 0.004818495856418 0.0 0.0 0.0 0.0 |
| The fatty acid cycling model 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The nlrp3 inflammasome 1.0 10.0 10.0 0.0938999510605359 0.0 0.0 0.0 0.0 |
| The phototransduction cascade 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The retinoid cycle in cones daylight vision 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| The role of gtse1 in g2 m progression after g2 checkpoint 1.0 67.0 1.5350474441383533 0.4844502219581325 0.0 0.0 0.0 0.0 |
| The role of nef in hiv 1 replication and disease pathogenesis 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Thrombin signalling through proteinase activated receptors pars 0.0 21.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Thromboxane signalling through tp receptor 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ticam1 dependent activation of irf3 irf7 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ticam1 rip1 mediated ikk complex recruitment 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ticam1 traf6 dependent induction of tak1 complex 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tie2 signaling 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tight junction interactions 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tlr3 mediated ticam1 dependent programmed cell death 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnf receptor superfamily tnfsf members mediating non canonical nf kb pathway 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnf signaling 0.0 39.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr1 induced nfkappab signaling pathway 0.0 28.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr1 induced proapoptotic signaling 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr1 mediated ceramide production 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tnfr2 non canonical nf kb pathway 1.0 58.0 1.7790182527024632 0.4363210249842685 0.0 0.0 0.0 0.0 |
| Tnfs bind their physiological receptors 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Toll like receptor 9 tlr9 cascade 0.0 75.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Toll like receptor cascades 0.0 103.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Toll like receptor tlr1 tlr2 cascade 0.0 70.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Toxicity of botulinum toxin type d botd 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates metabolic genes 0.0 84.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of caspase activators and caspases 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of cell cycle genes 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of cell death genes 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of death receptors and ligands 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of dna repair genes 0.0 61.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in cytochrome c release 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in g1 cell cycle arrest 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of genes involved in g2 cell cycle arrest 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tp53 regulates transcription of several additional cell death genes whose specific roles in p53 dependent apoptosis remain uncertain 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf3 dependent irf activation pathway 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated induction of tak1 complex within tlr4 complex 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated irf7 activation 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated irf7 activation in tlr7 8 or 9 signaling 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Traf6 mediated nf kb activation 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking and processing of endosomal tlr 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking of ampa receptors 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking of glur2 containing ampa receptors 0.0 11.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trafficking of myristoylated proteins to the cilium 1.0 4.0 10.0 0.0386632862857637 0.0 0.0 0.0 0.0 |
| Trail signaling 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trans golgi network vesicle budding 0.0 69.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription coupled nucleotide excision repair tc ner 0.0 82.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription of e2f targets under negative control by dream complex 0.0 19.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription of e2f targets under negative control by p107 rbl1 and p130 rbl2 in complex with hdac1 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcription of the hiv genome 0.0 67.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional activation of mitochondrial biogenesis 0.0 51.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional activity of smad2 smad3 smad4 heterotrimer 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by e2f6 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by mecp2 0.0 45.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx1 1.0 149.0 0.678951678951679 0.7722229142029041 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx2 1.0 100.0 1.0199979593918989 0.6285936102034135 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by runx3 1.0 86.0 1.1896613190730838 0.5730986271016891 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by small rnas 1.0 57.0 1.810966810966811 0.4307061333231872 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by the ap 2 tfap2 family of transcription factors 0.0 27.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by tp53 0.0 333.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation by ventx 0.0 37.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of granulopoiesis 0.0 34.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of pluripotent stem cells 0.0 16.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of testis differentiation 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transcriptional regulation of white adipocyte differentiation 0.0 68.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transferrin endocytosis and recycling 1.0 18.0 5.98871063576946 0.1626892876910785 0.0 0.0 0.0 0.0 |
| Translation 3.0 289.0 1.0608463701247206 0.5425017189276895 0.0 0.0 0.0 0.0 |
| Translation of replicase and assembly of the replication transcription complex 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translation of sars cov 1 structural proteins 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translation of sars cov 2 structural proteins 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translesion synthesis by polh 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translesion synthesis by polk 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translesion synthesis by y family dna polymerases bypasses lesions on dna template 0.0 41.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Translocation of slc2a4 glut4 to the plasma membrane 1.0 66.0 1.5588189588189587 0.4793101444108065 0.0 0.0 0.0 0.0 |
| Transmission across chemical synapses 0.0 139.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport and synthesis of paps 1.0 4.0 10.0 0.0386632862857637 0.0 0.0 0.0 0.0 |
| Transport of bile salts and organic acids metal ions and amine compounds 0.0 32.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of connexons to the plasma membrane 0.0 14.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of fatty acids 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of inorganic cations anions and amino acids oligopeptides 2.0 44.0 4.885325558794946 0.0690620672163432 0.0 0.0 0.0 0.0 |
| Transport of mature mrnas derived from intronless transcripts 1.0 43.0 2.417989417989418 0.3460310778663031 0.0 0.0 0.0 0.0 |
| Transport of mature transcript to cytoplasm 1.0 81.0 1.2646464646464646 0.5513512032975088 0.0 0.0 0.0 0.0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of nucleotide sugars 1.0 4.0 10.0 0.0386632862857637 0.0 0.0 0.0 0.0 |
| Transport of organic anions 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Transport of small molecules 12.0 377.0 3.635491905354919 0.0003052601031321 0.0 0.0 0.0 0.0 |
| Transport of the slbp dependant mature mrna 1.0 36.0 2.903607503607504 0.299132167535026 0.0 0.0 0.0 0.0 |
| Transport of vitamins nucleosides and related molecules 1.0 21.0 5.088888888888889 0.1871299927573601 0.0 0.0 0.0 0.0 |
| Transport to the golgi and subsequent modification 1.0 148.0 0.6836391122105407 0.7699332370232862 0.0 0.0 0.0 0.0 |
| Trif mediated programmed cell death 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Triglyceride biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Triglyceride catabolism 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Triglyceride metabolism 0.0 20.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tristetraprolin ttp zfp36 binds and destabilizes mrna 0.0 17.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna aminoacylation 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna modification in the mitochondrion 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna modification in the nucleus and cytosol 0.0 43.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna processing 1.0 109.0 0.934156378600823 0.6604325757838254 0.0 0.0 0.0 0.0 |
| Trna processing in the mitochondrion 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Trna processing in the nucleus 1.0 60.0 1.7183701420989557 0.4473868461248688 0.0 0.0 0.0 0.0 |
| Trp channels 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tryptophan catabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Type i hemidesmosome assembly 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tyrosine catabolism 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Tysnd1 cleaves peroxisomal proteins 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Ub specific processing proteases 3.0 151.0 2.078852047924213 0.1847545446978684 0.0 0.0 0.0 0.0 |
| Ubiquinol biosynthesis 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uch proteinases 1.0 79.0 1.2973322973322974 0.5423482911753763 0.0 0.0 0.0 0.0 |
| Unblocking of nmda receptors glutamate binding and activation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Unfolded protein response upr 2.0 75.0 2.802068772714565 0.1674383799538608 0.0 0.0 0.0 0.0 |
| Unwinding of dna 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uptake and actions of bacterial toxins 0.0 23.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uptake and function of anthrax toxins 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Uptake and function of diphtheria toxin 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Urea cycle 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vasopressin regulates renal water homeostasis via aquaporins 0.0 25.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegf ligand receptor interactions 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegfr2 mediated cell proliferation 0.0 15.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vegfr2 mediated vascular permeability 0.0 22.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vesicle mediated transport 6.0 546.0 1.1295508274231678 0.4480255544437777 0.0 0.0 0.0 0.0 |
| Viral messenger rna synthesis 1.0 44.0 2.361522198731501 0.3524722176470324 0.0 0.0 0.0 0.0 |
| Visual phototransduction 0.0 40.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin b1 thiamin metabolism 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin b2 riboflavin metabolism 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin b5 pantothenate metabolism 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin c ascorbate metabolism 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vitamin d calciferol metabolism 1.0 8.0 10.0 0.0758460972151271 0.0 0.0 0.0 0.0 |
| Vldl assembly 0.0 3.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vldl clearance 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vldlr internalisation and degradation 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Voltage gated potassium channels 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Vxpx cargo targeting to cilium 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wax and plasmalogen biosynthesis 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt ligand biogenesis and trafficking 0.0 9.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt mediated activation of dvl 0.0 8.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt5a dependent internalization of fzd2 fzd5 and ror2 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Wnt5a dependent internalization of fzd4 0.0 13.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Xenobiotics 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Yap1 and wwtr1 taz stimulated gene expression 0.0 10.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zbp1 dai mediated induction of type i ifns 0.0 18.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zinc efflux and compartmentalization by the slc30 family 0.0 5.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zinc influx into cells by the slc39 gene family 0.0 7.0 0.0 1.0 0.0 0.0 0.0 0.0 |
| Zinc transporters 0.0 12.0 0.0 1.0 0.0 0.0 0.0 0.0 |
|
|
